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| INTRODUC TI ON
Glioma, which represents approximately 47.1% of all CNS malignant tumours, is considered to be the most lethal primary brain tumour. 1, 2 Despite recent advances in surgery, chemotherapy and radiotherapy, the prognosis of glioma has not improved significantly, whereas patients with glioma still present a dismal outcome with a poor median survival time of only 12-15 months. 3, 4 Therefore, precise gene-targeted therapy is expected to become an effective therapeutic strategy for glioma.
Numerous evidence indicate that long non-coding RNAs (lncRNAs)
act as an important part in controlling the malignant progression of human tumours at gene expression level in almost every aspect of biological processes. 5, 6 Secretory carrier membrane protein 1 (SCAMP1)
functions as a carrier and participates in post-Golgi recycling pathway. 7 Accumulating reports have suggested that dysregulation of SCAMP1
is intimately associated with the development of various tumours. [8] [9] [10] However, little is known about the functions of lncRNA SCAMP1 in glioma. MicroRNAs (miRNAs) have demonstrated that they exert crucial modulatory roles on the tumourigenesis and the progression of glioma. [11] [12] [13] miR-499a-5p, also known as miR-499-5p or miR-499, was found to act as a tumour suppressor in osteosarcoma and oesophageal carcinoma. 14, 15 However, the potential role of miR-499a-5p in glioma has not been reported.
Transcription factor LIM homeobox transcription factor 1, alpha (LMX1A) located in 1q24.1 is a family member of LIM homeoboxcontaining genes that encode LIM-homeodomains. 16 Increasing researches have revealed that LMX1A is a key participant in modulating biological behaviours of varied human tumours. [17] [18] [19] Overexpression of LMX1A was associated with shorter survival and advanced clinicopathologic parameters in pancreatic ductal adenocarcinomas. 18 Moreover, LMX1A was reported to produce oncogenic effects on tumour development of cervical cancer. 19 However, the mechanisms underlying the role of LMX1A in glioma remain unclarified. NLR family, CARD domain containing 5 (NLRC5) is a member of the NLR protein family, which plays a critical role in cytokine response and regulation of immune responses. 20 Growing studies have shown that NLRC5 is involved in multiple human tumour progression. 21, 22 For instance, overexpression of NLRC5 promoted the development of hepatocellular carcinoma by targeting the Wnt/β-catenin signalling pathway. 22 However, whether NLRC5 is involved in the malignant progression of glioma was still unclear.
In our study, the expression levels of SCAMP1, miR-499a-5p, LMX1A and NLRC5 were investigated in glioma tissues and cell lines, meanwhile, the effects on regulating malignant progression of glioma and cross-talk among SCAMP1, miR-499a-5p, LMX1A and NLRC5 were completely clarified. Our findings may provide a novel therapeutic strategy for glioma.
| MATERIAL S AND ME THODS

| Clinical specimens
A total of 31 glioma specimens and six normal brain tissues (NBTs) 
| Cell lines and cultures
Normal human astrocyte (NHA) cells were purchased from Sciencell Research Laboratories (Carlsbad, CA) and human glioma U87, U251 and HEK293T cells were purchased from Shanghai
Institutes for Biological Sciences Cell Resource Center. NHA cells grown in astrocyte medium and U87, U251, HEK293T cells were cultured in Dulbecco's modified Eagle medium (DMEM)/high glucose mixed with 10% foetal bovine serum (Gibco, Carlsbad, CA).
All cells were maintained in a humidified incubator at 37°C with 5% CO2.
| Cell transfection
Short-hairpin RNA (shRNA) against SCAMP1, LMX1A and NLRC5 gene, as well as their non-targeting sequences were constructed in pGPU6/GFP/Neo vector from GenePharama (Shanghai, China).
Full-length SCAMP1, LMX1A and NLRC5 gene was constructed in pIRES2-EGFP (GenScript, Piscataway, NJ 
| RNA isolation and quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from the tissues and cells according to Trizol 
| Western blot analysis
Equal amounts of protein samples were separated using 8% or 10% sodiumdodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and then electrophoretically transferred to a polyvinylidene difluoride membrane (Millipore, Shanghai, China). After blocking 2 hours at room temperature, the membranes were incubated overnight at 4°C with primary antibodies as below: LMX1A (1:1000, abcam, ab31006, EUGENE, USA), NLRC5 (1:1000, abcam, ab105411, EUGENE, USA), β-catenin, c-Myc, cyclin D1, MMP-7 (1:1000, Cell
Signaling Technology, Beverly, MA) and GAPDH，β-actin (1:5000, Proteintech, China). After incubated 2 hours at room temperature with HRP-conjugated secondary antibodies, protein bands were visualized using ECL (Beyotime) and detected using ECL Detection Systems (Thermo Scientific, Beijing, China). The relative expression was calculated based on the internal control GAPDH or β-actin. 
| Cell proliferation assay
| Cell migration and invasion assays
For migration assay, U87 and U251 cells were resuspended in serumfree medium at a density of 2 × 10 5 cells/mL, then 100 μL cell suspension was seeded into the upper chamber of a 24-well transwell chamber (Costar, Corning, NY), meanwhile 600 μL DMEM/high glucose medium containing 10% FBS was added to the lower chamber. 
| Apoptosis analysis
Annexin V-PE/7-AAD (BD, Biosciences) was employed to detect cell apoptosis. According to the manufacturer's instruction, U87 and U251 cells were collected and washed with cold phosphate-buffered saline twice, then stained 15 minutes with Annexin V-PE/7AAD
at room temperature. The apoptotic fractions were then analysed using flow cytometry (FACScan, BD Biosciences).
| Dual-luciferase reporter assays
The predicted miR-499a-5p binding sequence in SCAMP1 and 
| Human miRNA microarray analysis
The sample preparation, microarray hybridization and miRNAs analysis were performed by Kangchen Bio-tech (Shanghai, China). 
| RNA immunoprecipitation
| Tumour xenografts in nude mice
Stable expression glioma cells for in vivo study was established as following steps. Lentivirus encoding miR-499a-5p was generated 
| Statistical analysis
Experimental data are presented as the mean ± standard deviation (SD) from at least three independent experiments. SPSS 22.0 software was used for statistical analysis with the Student's t test, oneway ANOVA, Pearson chi-square test or Log-rank test. Differences were considered statistically significant when P < 0.05.
| RE SULTS
| SCAMP1 was up-regulated in glioma and overexpressed SCAMP1 was correlated with poor prognosis of glioma patients
The expression levels of SCAMP1 in NBTs, glioma tissues, NHA 
| miR-499a-5p was down-regulated and manifested a tumour suppressor in glioma
miRNAs microarray analysis was employed to identify that miR-499a-5p was remarkably up-regulated in glioma cells when SCAMP1 knockdown, implying miR-499a-5p may participate in SCAMP1-induced modulation on glioma cells ( Figure S1 ).
Subsequently, as shown in Figure 2A -C, miR-499a-5p expression was proven to be significantly down-regulated in glioma tissues, U87 and U251 cell lines compared with NBTs and NHA respectively. Similarly, the expression level of miR-499a-5p was negatively correlated with the progression of glioma pathological grade.
Moreover, Kaplan-Meier survival analyses demonstrated that lower miR-499a-5p expression levels led to poorer prognosis of glioma patients and were associated with advanced pathological grade in 31 glioma patients ( Figure 2B and Table S2 ). To assess the functions of miR-499a-5p in glioma, U87 and U251 cells were transfected with miR-499a-5p-agomir or antagomir. As shown in Figure 2D -F, up-regulation of miR-499a-5p significantly decreased the proliferation, migration and invasion ability, meanwhile enhanced apoptosis of glioma cells compared with the pre-NC group. These evidence above inferred that miR-499a-5p exerted tumour-suppressive functions in glioma cells.
| miR-499a-5p targeted SCAMP1 and its expression was negatively regulated by SCAMP1
Using bioinformatics database (Starbase), SCAMP1 was identified as a potential target of miR-499a-5p. To clarify whether SCAMP1 could bind to miR-499a-5p through the putative binding site, the expression of miR-499a-5p in U87 and U251 cells transfected with sh-SCAMP1 was firstly detected. Results showed that the miR-499a-5p expression was significantly up-regulated after SCAMP1 knockdown ( Figure 3A) . Conversely, the SCAMP1 expression in glioma cells transfected with miR-499a-5p agomir was remarkably decreased ( Figure 3B ). Dual-luciferase assay was further quantified the interaction between SCAMP1 and miR-499a-5p. As shown in Figure 3C -D, the luciferase activity in SCAMP1-Wt + pre-miR-499a-5p group was considerably attenuated when compared with that in SCAMP1-Wt + pre-NC group. In addition, RIP assay showed that the expressions of SCAMP1 and miR-499a-5p were both increased in the anti-Ago2 group compared with that in anti-normal group, suggesting SCAMP1 and miR-499a-5p were in an RNA-induced silencing complex (RISC) ( Figure 3E ). Therefore, results above indicated that there was a reciprocal repression feedback loop between SCAMP1
and miR-499a-5p.
| miR-499a-5p mediated the tumoursuppressive effects of SCAMP1 knock-down on glioma cells
To investigate whether miR-499a-5p could regulate the effects of SCAMP1 inhibition on glioma cells, U87 and U251 cells were 
| Knockdown of LMX1A restrained cell proliferation, migration and invasion of glioma cells while promoting apoptosis
Bioinformatics database (TargetScan) was used to identify that LMX1A was a potential downstream target of miR-499a-5p. To confirm our hypothesis, the expression levels of LMX1A in glioma tissues and cells were detected. Western blot assay showed that LMX1A was up-regulated in glioma tissues and cell lines compared with NBTs and NHA, moreover, the expression level 
| NLRC5 was involved in LMX1A-mediated modulation on malignant progression of glioma cells and exerted an oncogenic role via activating the Wnt/β-catenin signalling pathway
NLRC5 was inferred as a downstream gene of LMX1A by the bioinformatics databases (DBTSS HOME and JASPAR). To ascertain our hypothesis, the expression levels of NLRC5 in glioma tissues and cells were firstly detected. As shown in Figure 6A bound to the promoter of NLRC5 in U87 and U251 cells. As schematic representation displayed, the putative LMX1A binding site located at the NLRC5 promoter region 1168 bp upstream of TSS. Immunoprecipitated DNA was amplified by PCR. Normal rabbit IgG was used as a negative control. (J) Western blot assay showed the expression levels of β-catenin, c-Myc, cyclin D1, MMP-7 in U87 and U251 cells treated with NLRC5 knockdown. Data are presented as the mean ± SD (n = 3, each group). **P < 0.01 vs sh-NLRC5-NC group Accumulating reports suggested that deregulation of Wnt/β-catenin signalling pathway is considered as an important marker in various human tumours. 23 Nevertheless, whether Wnt/β-catenin signalling pathway was involved in NLRC5-induced malignant progression of glioma cells remains elusive. To deeper reveal the molecular mechanism of the NLRC5 oncogenic roles, the activity of Wnt/β-catenin signalling pathway was examined. As shown in Figure 6J , the expression of β-catenin, c-Myc, cyclin D1 and MMP-7 was significantly down-regulated after NLRC5 was knockdown. Furthermore, overexpressed NLRC5 remarkably up-regulated the activity of Wnt/β-catenin signalling pathway ( Figure S3D ). Consequently, data above determined that NLRC5 accelerated malignant progression of glioma cells via enhancing the Wnt/β-catenin signalling pathway.
| Down-regulation of SCAMP1 combined with overexpression of miR-499a-5p inhibited tumour xenograft growth while exhibited higher survival ability
In vivo study further ascertained the above findings. The results
showed that the tumour volumes of sh-SCAMP1, pre-miR-499a-5p
and sh-SCAMP1 + pre-miR-499a-5p group were smaller than the F I G U R E 7 In vivo study. (A) The nude mice and the sample tumours from respective groups were shown. (B) Tumour xenograft growth curves in subcutaneous implantation assay were shown. Tumour volume was calculated every 4 days after injection and the tumour was resected after 40 days. Data represent mean ± SD (n = 10, each group). *P < 0.05 vs control group, # P < 0.05 vs sh-SCAMP1 group, ▲P < 0.05 vs pre-miR-499a-5p group. (C) Survival curves from representative nude mice injected into the right striatum in orthotopic inoculations assay were shown (n = 10, each group). P < 0.05 (sh-SCAMP1, pre-miR-499a-5p and sh-SCAMP1 + pre-miR-499a-5p groups vs control group) control group. Additionally, down-regulation of SCAMP1 combined with overexpression of miR-499a-5p presented the smallest tumour volume among all groups ( Figure 7A-B) . As shown in Figure 7C , the survival analysis in orthotopic inoculations assay manifested that the mice in the sh-SCAMP1, pre-miR-499a-5p and sh-SCAMP1 + premiR-499a-5p groups obtained longer survival time compared with control group, moreover the mice treated with sh-SCAMP1 + premiR-499a-5p had the longest survival time.
| D ISCUSS I ON
In this study, we confirmed that SCAMP1 was overexpressed in glioma tissues and cell lines. In addition, SCAMP1 knockdown significantly inhibited the malignant biological behaviours of glioma cells.
On the contrary, the miR-499a-5p expression was down-regulated and functioned as a tumour suppressor in glioma cells. Furthermore, we affirmed that miR-499a-5p expression was negatively regulated by the miRNA sponges role of SCAMP1. LMX1A and NLRC5
were highly expressed in glioma tissues and cell lines, knockdown of LMX1A or NLRC5 obviously impeded the malignant progression of glioma cells. Moreover, the LMX1A expression was inhibited by miR-499a-5p via directly targeting the LMX1A 3′-UTR, meanwhile the NLRC5 expression could be stimulated by LMX1A through binding to its promoter region in a sequence-dependent manner.
Consequently, the molecular mechanism revealed that knockdown of SCAMP1 increased miR-499a-5p expression, which hindered the expression of LMX1A and NLRC5, further led to carcinostatic effects on glioma cells by repressing the activity of Wnt/β-catenin signalling pathway. Strikingly, SCAMP1 knockdown combined with miR-499a-5p overexpression predominantly reduced xenograft tumour growth and elongated the nude mice survival time.
Recently, lncRNAs have been proved to play an important regulatory role on the malignant progression of copious human tumours. [24] [25] [26] In particular, different lncRNAs exhibit distinct gene expression patterns in glioma, such as CRNDE and Linc00152, promoting malignant progression of glioma, while Gas5 exerts tumour-suppressive functions in glioma cells. [27] [28] [29] In previous studies, 3′-UTR. 40 miR-370 was also reported that exerted tumour-suppressive function in glioma cells by directly binding to CCNE2 3′-UTR. 41 In our study, using bioinformatics database (TargetScan) combined with dual-luciferase assay certified that LMX1A was directly targeted by miR-499a-5p. Then we discovered that LMX1A expression was negatively modulated by miR-499a-5p through binding to LMX1A 3′-UTR. In addition, our research showed LMX1A was overexpressed in glioma tissues and cell lines, meanwhile, up-regulation of LMX1A significantly enhanced the proliferation, migration and invasion as well as suppressed apoptosis, implying that LMX1A exerts oncogenic effects on glioma cells. In earlier studies, LMX1A
expression was found to be up-regulated in glioma and showed positive correlation with histologic grade and clinical stage, which was consistent with our finding. 42 More importantly, results showed that overexpressed LMX1A obviously rescued the miR-499a-5p-induced tumour-suppressive effects on glioma cells, expositing that miR-499a-5p impeded the malignant progression of glioma cells via reducing LMX1A expression.
NLRC5 belongs to NLR family and plays a physiologically important role in the maintenance of immune homoeostasis. 43 Recently, the oncogenic role of NLRC5 in human tumours immensely attracts people's attention. 44, 45 In our research, the expression levels of NLRC5 were found that significantly elevated in glioma tissues and cell lines. In addition, NLRC5 knockdown remarkably restrained the biological behaviours of glioma cells, which demonstrating that NLRC5 acts as a carcinogen in glioma cells. In the earlier studies, NLRC5 was also affirmed highly expressed in hepatocellular carcinoma cells and promoted cell proliferation. 44 What's more, high expression of NLRC5 was correlated with poor survival of non-small cell lung cancer patients. 45 These studies further supported our findings.
As mentioned above, using bioinformatics database (DBTSS HOME and JASPAR), we discovered that the promoter region of and then promoted glioma cells growth and invasion. 51 Moreover, inhibition of the Wnt/β-catenin signalling pathway by miR-96 knockdown suppressed the proliferation and colony formation of glioma cells. 52 In previous research, we found the Wnt/β-catenin signalling pathway was stimulated by NLRC5 and played oncogenic role in hepatocellular carcinoma 22 . However, whether Wnt/β-catenin signalling pathway participated in NLRC5-induced malignant behaviours in glioma cells needs to be explored. Our studies revealed that reduction in NLRC5 abundance significantly repressed the activity of Wnt/β-catenin signalling pathway in glioma cells. Therefore, data above clarified that LMX1A knockdown obviously attenuated the activity of Wnt/β-catenin signalling pathway by down-regulating NLRC5 expression and restrained malignant behaviours of glioma cells. The underlying molecular mechanism of the tumour-suppressive functions elicited by SCAMP1 knockdown is schematically presented in Figure 8 .
In summary, our study revealed that LncRNA SCAMP1 plays an oncogenic role while miR-499a-5p exerts tumour-suppressive functions in glioma cells. SCAMP1 could increase LMX1A by negative regulating miR-499a-5p expression in glioma cells. LMX1A
transcriptionally activates the NLRC5 expression, which promotes the malignant biological behaviours of glioma cells through stimulating Wnt/β-catenin signalling pathway. In conclusion, the SCAMP1/ miR-499a-5p/LMX1A/NLRC5 axis serves as a critical regulator of tumourigenesis and progression of glioma, providing a novel therapeutic strategy for glioma treatment.
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